US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Narcolepsy

Recent news which mentions Narcolepsy

Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Tickers AVDL IBB NEWS
Tags Analyst Ratings Narcolepsy Broad U/S/ Equity ETFs
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
Tickers TAK TKPHF
Tags Market News Biotech Briefs
From Benzinga
Needham Initiates Coverage With Buy For This Narcolepsy Player
Tickers AVDL JAZZ
Tags Price Target Initiation Market News
From Benzinga
Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med
Tickers JAZZ
Tags Narcolepsy Benzinga FDA
From Benzinga
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
Tickers TAK TKPHF
Tags Health Care Breakthrough Therapy Drug Narcolepsy
From Benzinga
NLS Pharma Stock Gains As Its Narcolepsy Candidate To Enter Mid-Stage Study Next Month
Tickers NLSP
Tags Benzinga News FDA
From Benzinga